What did @andypbodybuilding actually say?
Andy says he has been dealing with a hip injury for "maybe two years" and a newer pec injury that "kind of feels like a micro tear." His solution: injecting a BPC-157/TB-500 combo "right into" the affected area, combined with a topical balm called Rhino Rub from Strate Labs. He credits the injections for his hip issues having "pretty much gone away" and is hoping for the same outcome with his chest. He also gives specific dosing guidance in the caption, citing 600mcg three times weekly for two to three weeks.
To be clear about what this is: Andy is a bodybuilder documenting personal experience, not a clinician. He is self-diagnosing injuries, self-administering subcutaneous or intramuscular peptide injections, and recommending a dosing protocol to his 18,500 viewers. That context matters enormously when evaluating the claims.
Does the science back this up?
Partially, but far less than Andy implies. The animal data on BPC-157 is genuinely interesting, but human clinical trials are essentially nonexistent at this point.
BPC-157 is a synthetic peptide derived from a protein found in gastric juice. Rodent studies, including work by Sikiric et al. (2018, Current Pharmaceutical Design) and multiple earlier publications from the same Croatian research group, show accelerated tendon-to-bone healing, reduced inflammation, and angiogenic effects in rats. TB-500 is a synthetic fragment of Thymosin Beta-4, which has shown wound-healing and anti-inflammatory properties in animal models (Goldstein & Kleinman, 2015, Annals of the New York Academy of Sciences).
The problem: neither peptide has completed Phase II or Phase III clinical trials in humans for musculoskeletal injuries. The World Anti-Doping Agency has banned TB-500 since 2012 precisely because of its performance-enhancing potential, not because of confirmed efficacy. Claiming these peptides healed a two-year hip injury based on personal experience, without a control condition, is a significant logical leap.
What did they get wrong (or right)?
Andy gets credit for one thing: he frames this as his personal experience rather than a guaranteed outcome. That is more honest than a lot of peptide content on TikTok.
What he gets wrong is more serious. First, his caption recommends specific doses (600mcg, three times weekly) to a general audience without any medical context. That is not responsible content, regardless of platform. Second, injecting directly "into the pec" with a self-diagnosed micro tear carries real infection and injury risk. There is no mention of sterile technique, sourcing verification, or medical supervision. Third, the topical Rhino Rub product presents a separate problem: the bioavailability of BPC-157 through intact skin is not established in any published literature. The claim that a topical peptide formulation delivers therapeutic concentrations to deep muscle tissue is speculative at best.
The two-year hip injury resolving is also not clearly attributable to the peptides. Time, rest, and reduced training load are confounders Andy does not acknowledge.
What should you actually know?
BPC-157 and TB-500 are not FDA-approved drugs. They are sold as research chemicals or, in some cases, as compounded preparations through telehealth platforms. That distinction matters legally and clinically. The FDA issued warnings in 2022 about unapproved peptide products, specifically citing safety and manufacturing concerns.
If you are dealing with a genuine soft tissue injury, the evidence base for physical therapy, platelet-rich plasma (PRP), and in some cases corticosteroid injections is substantially stronger than for these peptides. A 2021 systematic review by Fitzpatrick et al. (British Journal of Sports Medicine) found PRP superior to placebo for chronic tendinopathy in several controlled trials.
Peptide research is a legitimate and evolving field. But "evolving" means the evidence is not there yet for confident clinical recommendations. Anyone considering these compounds should do so under medical supervision, with sourced products tested for purity, and with realistic expectations about what the current data actually supports.